Cargando…

Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study

PURPOSE: To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain. METHODS: Retrospective, multicenter, and observational study conducted on five third-level Spanish hospitals, between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz-Moreno, José M., Arias, Luís, Abraldes, Maximino J., Montero, Javier, Udaondo, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450213/ https://www.ncbi.nlm.nih.gov/pubmed/34110547 http://dx.doi.org/10.1007/s10792-021-01906-x

Ejemplares similares

Management of Wet Age-Related Macular Degeneration in Spain: Challenges for Treat and Extend Implementation in Routine Clinical Practice
por: García-Layana, A., et al.
Publicado: (2019)

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
por: Ruiz-Moreno, José Mª, et al.
Publicado: (2008)

Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN(®)) and Follow-Up Considerations/Recommendations
por: Adán, Alfredo, et al.
Publicado: (2020)

A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2021)

Incremental economic burden associated with exudative age-related macular degeneration: a population-based study
por: Kim, Siin, et al.
Publicado: (2019)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Early and intermediate age-related macular degeneration: update and clinical review
por: García-Layana, Alfredo, et al.
Publicado: (2017)

Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2023)

Regional differences in the global burden of age-related macular degeneration
por: Xu, Xiayan, et al.
Publicado: (2020)

Burden and Presentation of Age-Related Macular Degeneration among Nigerians
por: Okonkwo, Ogugua N., et al.
Publicado: (2021)

Clinical and economic burden of neovascular age-related macular degeneration by disease status: a US claims-based analysis
por: Almony, Arghavan, et al.
Publicado: (2021)

Challenges in Diabetic Macular Edema Management: An Expert Consensus Report
por: Udaondo, Patricia, et al.
Publicado: (2021)

The social and economic burden of frontotemporal degeneration
por: Galvin, James E., et al.
Publicado: (2017)

The national and subnational prevalence and burden of age–related macular degeneration in China
por: Song, Peige, et al.
Publicado: (2017)

The burden of neovascular age-related macular degeneration: a patient’s perspective
por: Spooner, Kimberly L, et al.
Publicado: (2018)

Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA
por: Ferreira, Alberto, et al.
Publicado: (2015)

Remote screening of retinal and optic disc diseases using handheld nonmydriatic cameras in programmed routine occupational health checkups onsite at work centers
por: Zapata, Miguel A., et al.
Publicado: (2020)

Correction: Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA
Publicado: (2015)

Intravitreal aflibercept for the treatment of patients with neovascular age-related macular degeneration in routine clinical practice in Latin America: the AQUILA study
por: Wu, Lihteh, et al.
Publicado: (2022)

Different Strategies for the Treatment of Age-Related Macular Degeneration in China: An Economic Evaluation
por: Wu, Bin, et al.
Publicado: (2016)

Intravitreal Aflibercept Treatment Strategies in Routine Clinical Practice of Neovascular Age-Related Macular Degeneration in Belgium: A Retrospective Observational Study
por: Ruys, Joke, et al.
Publicado: (2020)

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
por: García-Onrubia, Luis, et al.
Publicado: (2020)

Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration
por: Gohil, Rishma, et al.
Publicado: (2015)

Impact of neovascular age-related macular degeneration: burden of patients receiving therapies in Japan
por: Honda, Shigeru, et al.
Publicado: (2021)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Do Nutritional Supplements Have a Role in Age Macular Degeneration Prevention?
por: Pinazo-Durán, Maria D., et al.
Publicado: (2014)

Automatic Quantification Software for Geographic Atrophy Associated with Age-Related Macular Degeneration: A Validation Study
por: Ruiz-Moreno, José M., et al.
Publicado: (2020)

Serum 25-hydroxy vitamin D levels in age-related macular degeneration
por: Pérez Serena, Antonio, et al.
Publicado: (2022)

Critical Appraisal of Clinical Practice Guidelines for Age-Related Macular Degeneration
por: Wu, Annie M., et al.
Publicado: (2015)

Genetics and age-related macular degeneration: a practical review for the clinician
por: Schwartz, Stephen G, et al.
Publicado: (2016)

Financial burden and quality of life of informal caregivers of patients with wet age-related macular degeneration
por: Weyer-Wendl, Hannah, et al.
Publicado: (2016)

Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration
por: Arias, Luis, et al.
Publicado: (2010)

A Delphi Study to Detect Deficiencies and Propose Actions in Real Life Treatment of Neovascular Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2014)

Disease burden of age-related macular degeneration in China from 1990 to 2019: findings from the global burden of disease study
por: Zhang, Yichi, et al.
Publicado: (2021)

LAMELLAR MACULAR HOLES IN THE PRESENCE OF AGE-RELATED MACULAR DEGENERATION
por: Francone, Anibal, et al.
Publicado: (2020)

Pharmacogenetics and Age-Related Macular Degeneration
por: Schwartz, Stephen G., et al.
Publicado: (2011)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3fu97988ps7mompknrgqjleufs